|
| 37081044 | Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation. | Prostate Cancer Prostatic Dis | 2024 |
| 37661792 | Systematic review and meta-analysis of urinary incontinence prevalence and population estimates. | Neurourol Urodyn | 2024 |
| 37931277 | Sacral neuromodulation in the golden years: Treatment outcomes in elderly 75 years and older. | Can Urol Assoc J | 2024 |
| 36266993 | Clinical Applications of Machine Learning for Urolithiasis and Benign Prostatic Hyperplasia: A Systematic Review. | J Endourol | 2023 |
| 38082057 | Correction: Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthcare claims and utilization study. | Prostate Cancer Prostatic Dis | 2023 |
| 37556075 | Treating LUTS in Men with Benign Prostatic Obstruction: A Review Article. | Drugs Aging | 2023 |
| 37849957 | Procedural Intervention for Benign Prostatic Hyperplasia in Men â¿¥ Age 70 Years - A Review of Published Literature. | Clin Interv Aging | 2023 |
| 37479913 | A scoping review of office-based prostatic stents: past, present, and future of true minimally invasive treatment of benign prostatic hyperplasia. | World J Urol | 2023 |
| 37838991 | Aquablation versus TURP: 5-year outcomes of the WATER randomized clinical trial for prostate volumes 50-80 mL. | Can J Urol | 2023 |
| 37884615 | Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthcare claims and utilization study. | Prostate Cancer Prostatic Dis | 2023 |
| 37574143 | Aquablation in Patients on Antithrombotics: Assessment of Safety, Postoperative Bleeding Rates and Clinical Outcomes. | Urology | 2023 |
| 37729644 | Adverse Event Reporting of Commonly Used Gender-Specific Implantable Medical Devices in the United States. | J Patient Saf | 2023 |
| 35351540 | Disproportional signal of sexual dysfunction reports associated with finasteride use in young men with androgenetic alopecia: A pharmacovigilance analysis of VigiBase. | J Am Acad Dermatol | 2023 |
| 35689083 | Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study. | Prostate Cancer Prostatic Dis | 2023 |
| 37458744 | Evaluation of Canadian urology residency and fellowship program websites. | Can Urol Assoc J | 2023 |
| 37344470 | How I Do It: Optilume BPH catheter system. | Can J Urol | 2023 |
| 37344466 | Litigation associated with 5-alpha-reductase-inhibitor use: A Canadian legal database review. | Can J Urol | 2023 |
| 37107140 | Enterococcal Urinary Tract Infections: A Review of the Pathogenicity, Epidemiology, and Treatment. | Antibiotics (Basel) | 2023 |
| 37076022 | Change in Prostate Volume and Symptom Improvement in Men Treated With Rezūm Water Vapor Therapy. | Urology | 2023 |
| 37074746 | The impact of 5-ARI on perioperative and functional outcomes of GreenLight PVP: an analysis of the Global GreenLight Group database. | Can J Urol | 2023 |
| 37068148 | The role of quantitative MRI-based prostate zonal parameters in predicting clinically significant prostate cancer A U.S. cohort. | Can Urol Assoc J | 2023 |
| 36964042 | Minimally Invasive Treatments for Benign Prostatic Obstruction: A Systematic Review and Network Meta-analysis. | Eur Urol | 2023 |
| 37395472 | US patterns of care for urodynamic evaluation for BPH. | Neurourol Urodyn | 2023 |
| 37127467 | Industry Payments to American Editorial Board Members of Major Urology Journals. | Eur Urol | 2023 |
| 36821011 | Safety and efficacy of GreenLight PVP in octogenarians: evaluation of the Global GreenLight Group database. | World J Urol | 2023 |
| 36655731 | The patient burden of nocturnal polyuria in the United States: Results from the epidemiology of nocturnal polyuria (EpiNP) study. | Neurourol Urodyn | 2023 |
| 36808735 | Feasibility and preliminary clinical tolerability of low-field MRI-guided prostate biopsy. | Prostate | 2023 |
| 36779953 | How I Do It: Penthrox in Urology. | Can J Urol | 2023 |
| 36779946 | Surgical treatment for BPH refractory to medication: robotic water jet ablation vs. TURP functional outcomes from two FDA clinical trials. | Can J Urol | 2023 |
| 36579919 | Top Ten Tips Palliative Care Clinicians Should Know About Urological Care. | J Palliat Med | 2023 |
| 36463348 | Prostatic artery embolization compared to transurethral resection of the prostate and prostatic urethral lift: a real-world population-based study. | World J Urol | 2023 |
| 36708403 | Nocturnal polyuria in women: results from the EpiNP study. | Int Urogynecol J | 2023 |
| 36534154 | Functional outcomes of GreenLight 180-W photoselective vaporization in patients with large (⿥⿿80 cc) prostates: an analysis of over 3000 men in the Global Greenlight Group (GGG) database. | World J Urol | 2023 |
| 36797501 | Characterization of the histological response to the Butterfly Prostatic Retraction Device in patients with benign prostatic hyperplasia. | World J Urol | 2023 |
| 36762936 | Patients' Perspectives on Attributes While Choosing Minimally Invasive Surgery for Benign Prostatic Hyperplasia Procedures: Experience from Men Undergoing Water Vapor Thermal Therapy. | J Endourol | 2023 |
| 36758183 | Prostatic zonal parameters and lower urinary tract symptoms as quantified via magnetic resonance imaging. | Can Urol Assoc J | 2023 |
| 36486181 | Cost-utility of minimally invasive therapies vs. pharmacotherapy as initial therapy for benign prostatic hyperplasia A Canadian healthcare payer perspective. | Can Urol Assoc J | 2023 |
| 36863599 | Current Practice Patterns in the Surgical Management of Benign Prostatic Hyperplasia. | Urology | 2023 |
| 36410527 | Effect of Surgeon and Facility Volume on Outcomes of Benign Prostatic Hyperplasia Surgery: Implications of Disparities in Access to Care at High-Volume Centers. | Urology | 2023 |
| 36215409 | Differences in the Prevalence of Nocturnal Polyuria in the U.S. by Definition: Results From the Epidemiology of Nocturnal Polyuria Study. Reply. | J Urol | 2023 |
| 36070450 | An Evaluation of Sexual Function in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia in Men Treated with the Temporarily Implanted Nitinol Device. | J Endourol | 2023 |
| 34534195 | Characterizing Adverse Events Reporting for an Over-the-Counter Disposable Intravaginal Support Device for Stress Urinary Incontinence. | Female Pelvic Med Reconstr Surg | 2022 |
| 35474587 | Rezum to the rescue: Early outcomes of Rezum on patients with recurrent lower urinary tract symptoms after surgical interventions for benign prostatic enlargement. | Andrologia | 2022 |
| 35347413 | GreenLight photovaporization of the prostate in high-medical-risk patients: an analysis of the Global GreenLight Group (GGG) database. | World J Urol | 2022 |
| 35536677 | Adverse Events for Overactive Bladder Medications From a Public Federal Database. | Female Pelvic Med Reconstr Surg | 2022 |
| 35469810 | WATER vs WATER II 3-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80 cc and 80-150 cc Prostates. | Urology | 2022 |
| 35466513 | Rezūm therapy for ⿥80-mL benign prostatic enlargement: a large, multicentre cohort study. | BJU Int | 2022 |
| 35429425 | Rezūm water vapor therapy for catheter-dependent urinary retention: a real-world Canadian experience. | Can J Urol | 2022 |
| 35427376 | A comprehensive analysis of clinical, quality of life, and cost-effectiveness outcomes of key treatment options for benign prostatic hyperplasia. | PLoS One | 2022 |
| 35421039 | Manufacturer and User Facility Device Experience Reporting of Events Related to Transvaginal Mesh: Understanding the Data. | Female Pelvic Med Reconstr Surg | 2022 |